AnaCardio AB announced that it has received SEK 150 million in a round of funding led by Flerie Invest AB, and Industrifonden on September 7, 2022. The transaction also included participation from 3B Health Ventures, returning investors Karolinska Development AB , and individual investors Fredrik and Ann-Helene Ljungström.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.63 SEK | -1.21% | +0.62% | -4.00% |
26/04 | Karolinska Development AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
16/04 | Karolinska Development AB Announces That Björn Cochlovius Has Declined Re-Election | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.00% | 41.68M | |
-5.13% | 182B | |
+3.46% | 112B | |
-3.33% | 68.58B | |
+4.77% | 51.58B | |
+8.04% | 44.24B | |
+9.45% | 43.65B | |
+24.80% | 32.46B | |
+20.94% | 25.99B | |
-0.36% | 25.61B |
- Stock Market
- Equities
- KDEV Stock
- News Karolinska Development AB
- AnaCardio AB announced that it has received SEK 150 million in funding from Industrifonden, Karolinska Development AB, Flerie Invest AB, and other investors